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Objectives: to report the long term results of remote superficial femoral artery endarterectomy (RSFAE) with the MollRing
Cutter1 for the treatment of long segmental SFA occlusive disease.
Design: retrospective open study.
Patients and Methods: from March 1994 to August 2000 183 RSFAEs were performed in 164 selected patients (105
males, 120 procedures) with a median age of 63 years (43±84 years). Indications for operation were disabling intermittent
claudication in 129 procedures (70%), rest pain in 20 procedures (11%), and limb salvage in 34 procedures (19%). Follow
up consisted of clinical evaluation, ankle-brachial index measurements and duplex scanning.
Results: the mean follow-up time was 29.3 months. The mean length of the endarterectomised SFAs was 31 cm (range,
17±45 cm). The five year cumulative primary patency rate by means of life table analysis was 37.8+ 6.67% (SE).
Percutaneous transluminal balloon angioplasty and surgical re-intervention were performed in twenty-nine and four
patients respectively resulting in a primary assisted patency rate of 47.9+6.27%. Limb salvage was achieved in 30 of the 34
patients. Females had a statistically significant lower primary patency rate, i.e., 26 vs 45% (p-value 0.01).
Conclusions: the long term results of remote SFA endarterectomy show that it is a safe, effective and durable, minimally
invasive procedure. It also leaves open all other options for conventional bypass procedures. The five-year primary patency
rate is at least similar to prosthetic above-knee bypass surgery.
Key Words: Remote endarterectomy; MollRing Cutter1; Superficial femoral artery; Peripheral arterial occlusive disease;
Intermittent claudication.
Introduction
Treatment of long segmental occlusions or multiple
stenoses in the superficial femoral artery (SFA) is a
challenging field in vascular surgery for many dec-
ades already. Short occlusions or stenoses can be trea-
ted by percutaneous transluminal angioplasty (PTA).
However, long term patency for longer (410 cm)
occlusive lesions has been disappointing. The use of
stents in combination with angioplasty has not
altered these results, despite close surveillance and
early reintervention.1
Recent prospective randomised studies show that
prosthetic above-knee femoro-popliteal (AKFP)
bypass grafts have a five year primary patency rate
of 39±45%.2±4 This means no significant improvement
over the last twenty years. Venous bypass grafting has
a better patency rate. It might be the first option for
treatment, even when the vein has to be harvested
from another extremity than the affected leg as long
as it is autologous vein. However, many surgeons
believe that for above-knee bypass grafting it is better
to spare autologous venous material and save it for
future cardiovascular or peripheral surgery. Moreover,
an increasing number of patients do not have
adequate venous material.
Transluminal surgical endarterectomy dates back
more than 50 years to 1946, when the Portuguese
surgeon Cid dos Santos performed the first thrombo-
endarterectomy through two arteriotomies.5 Initial
enthusiasm was followed by an awareness of its lim-
itations and complications. Despite promising early
results, open and semi-closed endarterectomies were
largely abandoned in the 1970s. Several reports sug-
gested inferior results of an endarterectomy when
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compared to femoro-popliteal venous bypass
grafting.6,7 These retrospective, non-randomised
studies, often with historical control groups, compared
patency rates of vein bypass with endarterectomy.
Most series were comprised of small numbers of
patients and most did not differentiate between open
and semi-closed endarterectomies. Several other
important variables that could have influenced
patency rates (e.g., run-off score) were not evaluated.
In the late eighties and early nineties four reports
reappraised the semi-closed endarterectomy with a
ring stripper that achieved patency rates similar to
those of AKFP bypass graft.8±11
Since March 1994 our vascular surgery and radi-
ology departments have performed remote endarter-
ectomies using a ring strip cutter (MollRing Cutter1,
Vascular Architects, Inc., San Jose, CA, U.S.A.).12 This
procedure offers several advantages. It is minimally
invasive and avoids a second distal incision. It also
avoids use of prosthetic graft material, it can be used
in the absence of the saphenous vein, and it preserves
it for later cardiovascular or peripheral surgery. Fur-
thermore, conversion to a regular semi-closed endar-
terectomy or bypass surgery in the case of technical
failure, remains an option.
The purpose of this study is to report the long term
results of remote superficial femoral artery endarter-
ectomy (RSFAE) with the MollRing cutter and to
determine its place in the armament of the vascular
surgeon in the treatment of long segmental SFA occlu-
sive disease.
Materials and Methods
Patients
From March 1994 to August 2000 183 remote super-
ficial femoral artery endarterectomy procedures were
performed in 164 patients. Demographic data and risk
factors for atherosclerosis were collected. All proce-
dures were performed in the St Antonius Hospital
Nieuwegein, The Netherlands. Enrolment of patients
was equally spread over the years. Rutherford classi-
fication was used to assess the stage of ischaemia.13 In
the case of intermittent claudication at the first patient
contact a conservative regime was established; walk-
ing exercise, cessation of smoking, and antiplatelet
medication was started. When this conservative
regime was unsuccessful after 6 months patients
were scheduled for an RSFAE. Preoperative evalu-
ation included ankle-brachial pressure indices, colour
flow duplex scanning at our vascular laboratory, and
the extent of the lesion was visualised by angiography.
All patients suffered from SFA long segmental occlu-
sion or multiple stenoses and had a patent popliteal
artery with at least one crural runoff vessel. In our
hospital, both the vascular surgeons and interven-
tional radiologists discuss the patient's treatment
options. Patients with renal failure (defined as the
need for hemodialysis, peritoneal dialysis, or presence
of a functioning allograft) were excluded from this
study, because these patients tend to have significant-
ly inferior results to any other patient group.14,15
Technique of the RSC procedure
The technique of remote endarterectomy using the
MollRing Cutter has been described previously.12,16
This can be summarised as follows. The MollRing
Cutter is a modification of the original single ring
ringstripper with two shafts instead of one, which
telescope into each other. Two symmetric elliptical
rings are attached at a 135 angle to the most distal
part of each shaft (Fig. 1). The rings come in different
sizes, ranging from 5 to 10 millimetres inner diameter.
Both parallel rings have sharpened inner edges and
cut like a pair of scissors when they shear across each
other during telescoping the shafts.
Through a small groin incision the common femoral
artery is exposed. The most important part of the
operation is a meticulous dissection of the intima
core in the right cleavage plane allowing a smooth
introduction of the ring stripper. The ring stripper
(Vollmar Dissector, Aesculap1, South San Francisco,
CA, U.S.A.), is than advanced with a gentle, slow
rotating motion distally into the SFA beyond the
Fig. 1. The MollRing Cutter in open and closed position. The double
rings have sharpened inner edges, which make it possible to cut the
distal intima core like a pair of scissors.
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affected segment under fluoroscopic guidance. Then
the ring stripper is exchanged for a suitable MollRing
Cutter which is passed down along the same cleavage
plane until the same level is reached and the intima
core is remotely transected and removed (Fig. 2). This
makes a second incision to expose the popliteal artery
at the endpoint of the endarterectomised segment
unnecessary. To prevent any further distal dissection
after restoring bloodflow, a short stent (Palmaz, P204,
Cordis Endovascular, Warren, U.S.A.; Easy Wall stent,
Schneider Inc, U.S.A.; diameters 5±8 mm) is inserted
over a guidewire (Terumo1, Tokyo, Japan;
Schneider1, Zurich, Switzerland) to tack down the
distal intimal flap, covering both the endarterecto-
mised surface and proximal part of the artery
that is not endarterectomised.17 Finally, the whole
SFA is passed with a Fogarty1 Graft Thrombectomy
Catheter (Edwards Life-sciences, Vascular Division,
Irvine, CA, U.S.A.) in order to remove residual debris.
The arteriotomy is then extended proximally to
perform an open endarterectomy of the common fem-
oral artery or profundoplasty.
Fig. 2. (A) Insertion of the MollRing Cutter and advancing past the occluded segment at the distal SFA. (B) The intima core is cut
endoluminally. (C). The endarterectomised segment with a smooth distal endpoint after fixation of the distal intimal flap with a stent.
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Follow up
After the procedure, outpatient examinations were per-
formed at 1 week, 6 weeks and every 3 months for 1
year, and then annually. Routine surveillance consisted
of colour-flow duplex scanning in the vascular labora-
tory (HP Sonos 2000, Hewlett Packard Company,
Imaging System Division, Andover, MA, U.S.A.).
Clinical and haemodynamic sustained improvements
were evaluated by recurrent symptoms and ankle-
brachial blood pressure index measurements at every
follow-up visit. All patients were placed on antiplatelet
agents, i.e. aspirin, Persantin or Plavix at the surgeon's
discretion. Adverse patient outcomes including
wound complication, ipsilateral major amputation,
re-stenosis or re-occlusion, and the need for revision
were recorded. Primary patency is defined as uninter-
rupted patency of the treated artery or its anastomoses
without any procedures performed. If minor graft revi-
sions, such as PTA of restenosis of the treated artery or
adjacent arteries were necessary to prevent occlusion,
the artery was classified as assisted primary patency. In
the event arterial flow was restored by thrombectomy,
thrombolysis, or grafting after an occlusion, the
patency was classified as secondary. The decision for
reintervention was not based on strict criteria but was
made on basis of a combination of recurrent clinical
symptoms, declined ankle-brachial indices, and rest-
enoses seen on duplex scanning or angiography.
Statistical methods
Life table analysis was performed to calculate patency
and patient survival rates. Univariate analysis of vari-
ables was performed with the Log rank test. The limit of
statistical significance was set at p 0.05 (two-sided).
Results
One hundred and eighty-three consecutive limbs in
164 patients underwent a successful remote endarter-
ectomy procedure, using a MollRing Cutter. The
median age (range) was 63 years (43±84) years,
105 patients were male (120 procedures) and 59 were
female (63 procedures). Risk factors for atherosclerosis
are shown in Table 1. The indications for surgical
intervention were disabling intermittent claudication
in 129 (70%) procedures (Rutherford category 3), rest
pain in 20 (11%) procedures (Rutherford cat. 4), and
gangrene in 34 (19%) procedures (Rutherford cat. 5).
Thirty-three patients had a medical history of previ-
ous peripheral vascular intervention(s): eleven
patients had undergone an intervention within the
ipsilateral femoro-popliteal segment: aorta-bifemoral
bypass (2), occluded femoro-popliteal bypass (2), PTA
(5), PTA with stent placement (1), and femoral profun-
daplasty (1). Twenty-two patients had previously
undergone other peripheral vascular interventions:
aortobi-iliac prosthesis (5), PTA of the ipsilateral iliac
artery (5), PTA or bypass in the contralateral SFA (12).
In 95% of all cases the SFA was occluded, of which
65% extended over more than half of the femoro-
popliteal segment. In 143 (78%) cases there were two
or three runoff vessels and in 40 (22%) cases there was
single vessel runoff.
Technical and procedural success
Due to a perforation of the distal SFA or popliteal
artery, or due to technical difficulties in passing the
guidewire across the distal intimal edge, a second
incision at the distal end was required in four proce-
dures. In seven procedures placement of a proximal
PTFE (8 mm diameter) interposition graft was
required due to poor quality of the common femoral
artery. Conversion to bypass surgery was performed
in eleven cases due to a perforation of the SFA or due
to the technical inability to perform endarterectomy,
e.g., as a result of a too heavily calcified intima core.
The mean length (range) of the endarterectomised
segment was 31 cm (17±45 cm). The intima core was
usually removed in one piece. Postoperative compli-
cations that needed additional treatment were haem-
atoma in four cases and wound infection in seven
patients. One patient died as a result of a myocardial
infarction within 30 days after the procedure. The
median ankle-brachial index improved from 0.60
(0.14) preoperative to 0.96 (0.14) postoperative.
Clinical improvement of at least one stage, according
to the SVS/ISCVS criteria, was achieved in all patients.
Long-term follow up
Median follow-up time was 29.3 months with a range
from 1 to 84 months. Life table analysis shows a 1 and 5
Table 1. Associated diseases and risk factors for atherosclerosis.
Number of patients (%),
n 164
Diabetes 44 (27%)
Hypercholesterolaemia 44 (27%)
Hypertension 31 (19%)
Smoking 116 (70%)
Coronary artery disease 42 (26%)
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year patient survival rate of 94.7 and 70% respectively.
Of the 164 treated patients and 183 treated limbs
67 limbs occluded. The 5 year cumulative primary
patency rate by means of life-table analysis was
37.8 6.76% (SE) (Fig. 3). To give a five year primary
assisted patency rate of 47.9 6.27%, percutaneous
transluminal balloon (26) and stent (3) angioplasty
was performed in 29 patients (Fig. 3), and surgical
revision of the proximal and distal SFA was performed
in three and one patient respectively. The five-year
secondary patency rate was 49%, after embolectomy
(4), fibrinolysis with urokinase (2) and fibrinolysis
with surgical revision (8). Restenoses and occlusions
were equally distributed within the SFA and not
restricted to the stent or distal SFA region. In four of
the 34 patients presented with gangrene, limb salvage
was unsuccessful and three below-knee amputations
and one above-knee amputation were performed. Also,
in one patient with intermittent claudication a below-
knee amputation was necessary because of gangrene
following occlusion of the SFA after 23 months.
Females had a statistical significant lower five year
cumulative primary patency rate compared to males,
26 and 45% respectively (p value 0.01).
Discussion
For patients with long segmental SFA occlusive dis-
ease, femoro-popliteal bypass surgery with autolo-
gous venous or prosthetic material is the most
common treatment modality. However, conventional
surgical femoro-popliteal bypass surgery is associated
with multiple incisions, the associated risk of compli-
cations and the use of saphenous veins. RSFAE
offers a new safe and effective treatment of long seg-
mental SFA occlusive disease.14,18 Previous (surgical)
interventions in the ipsilateral SFA, are not necessarily
a contraindication.
In RSFAE the whole intima core is removed and a
complete disobliteration of the SFA is performed.
Complications that can occur during the process of
cleaving, transecting and removing the intima core
are a perforation of the SFA or a technical failure. In
the event of a perforation a second distal incision is
usually enough to solve the problem. A conversion to
a standard above knee prosthetic bypass can also still
be performed and a third possibility is a translumin-
ally placed ePTFE endolining. The latter is described
in previous studies and these patients were not
included in our study. The endolining reduces intimal
hyperplasia but patency rates are mostly influenced by
restenoses at the proximal and distal anastomoses.19,20
To prevent any further distal dissection after the
restoration of blood flow, the distal intimal flap has
to be tacked down by a stent. Because the distal edge
is located in the Hunter canal ± prone to movement ±
only a short stent or a flexible (longer) stent can be
used. This and a previous study show that the stented
area does not cause additional restenosis.21 However,
improvements in material, shape and the covering of
stents are ongoing. Covering a stent is believed to
reduce the incidence of stenoses at the site, while on
the other hand completely covering a stent compro-
mises the collaterals. We are currently evaluating a
new stent that combines the advantages of covered
and open stents. It is a spiral covered stent, which is
very flexible, and the specific shape adds the benefit of
not compromising the collaterals of the SFA and can
therefore be placed in a longer segment in the SFA.
Prior to placing the stent, the guide-wire has to be
passed across the distal intimal edge. In general this is
not a problem and it can be easily achieved under
fluoroscopic visualisation. If this is not possible, or
the wire causes a further dissection of the distal
lumen, the guide wire can be passed in a retrograde
fashion via the popliteal artery, also described by
Galland et al.22
The follow up after the procedure requires routine
annual colour-flow duplex scanning. This is a reliable,
patient friendly and cost effective procedure for diag-
nosing restenosis in the endarterectomised SFA.23,24
With no re-intervention at all a primary patency of
37.8% was achieved. Only twenty-nine radiological
reinterventions and four surgical reinterventions
were considered necessary giving a primary assisted
patency of 47.9%. Re-intervention was not required for
all restenoses, and neither all restenoses nor all occlu-
sions gave rise to clinical symptoms. This may be
explained by the continued development of a pre-
served collateral network during the period of full
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Fig. 3. Primary and primary assisted patency curves by life table
method, with number of patients at risk.
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patency and slow degradation of lumen patency of the
disobliterated segment, or the benefit of an adjunctive
deep femoral artery endarterectomy. The decision for
reintervention was made on basis of clinical symp-
toms or on basis of the time interval between the
RSFAE and restenosis. Results of a previous study of
our first RSFAE patients showed that revision of early
(51 year) recurrent stenoses improves the patency
rates but late restenoses developing after one year do
not seem to progress to reocclusion and may be trea-
ted conservatively.25
In three recent prospective randomised studies,
Green et al., Johnson et al. and Burger et al. presented
5-year primary patency rates of prosthetic above-knee
bypass surgery ranging from 38 to 45%.2±4 These
results are similar to the 5-year primary patency
rates of RSFAE in our study of 37.8%. Also recently,
Rosenthal et al. presented the medium-term results of
a multicentre study of remote endarterectomy in long-
segment SFA occlusive disease in 60 patients. Their
3-year primary patency rate of 61% supports our
results.26 Off course saphenous vein bypass surgery
is superior in its 5-year primary patency rate of 73%
but the saphenous vein can be better spared for later
cardiovascular surgery or is already harvested for that
purpose.3 Moreover, RSFAE is a minimal invasive
procedure, with less surgical exposure needed than
for semi-closed endarterectomy or any bypass proced-
ure. It creates less operative trauma and a reduction of
postoperative discomfort, leading to earlier recovery
and discharge of the patient as described in other
reports.20,27
Of interest is that females had a statistically less
primary patency rate than males, i.e., 26 vs 45%
respectively. This is not explained by the fact that
females have smaller diameter arteries. Statistical
analysis shows no significant relation between
patency and diameter of the MollRing Cutter (read
diameter of the SFA) used. Data comparing females
and males in above knee venous or prosthetic bypass
surgery is not available. Therefore we cannot state that
females should not be considered for RSFAE.
We believe that in the future the occurrence of rest-
enosis after remote endarterectomy can be reduced.
Four directions of research to overcome the problem
of intimal hyperplasia in endarterectomised superficial
femoral SFAs can be distinguished: gene and drug
therapy, endothelial cell seeding of the SFA or trans-
luminal placed endovascular grafts, and radiation or
brachy therapy. The availability and application of new
intra-operative technology may improve results from
the past. We think of intra-operative digital subtraction
angiography, angioscopy and intravascular ultrasono-
graphy (IVUS). With the help of these new modalities
the endarterectomised artery can be inspected more
accurately and intra-operatively endoluminal correc-
tions can be made. The question is, whether patency
improvements can be expected in above-knee venous
and prosthetic bypass surgery for this has not been the
case in the past 20 years.
Remote superficial femoral artery endarterectomy is
an effective, minimal invasive procedure. It has obvi-
ous advantages over prosthetic above-knee bypass
surgery and long-term patency rates are equal. More-
over, in case of failure all other options for conven-
tional bypass procedures are still available. Off course
randomised trials have to provide a final answer
about the place of RSFAE in the armament of the
vascular surgeon against long segmental SFA occlu-
sive disease and whether it should be considered as
first choice of treatment. At this time current studies at
improvements in RSFAE are performed and improve-
ments within RSFAE are to be expected.
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